REGENXBIO to Participate in Upcoming Investor Conferences

Rhea-AI Summary

REGENXBIO (Nasdaq: RGNX) will participate in three investor conferences in March 2026 with multiple fireside chats and webcasts available.

Events include Leerink Partners Global Healthcare on March 9, 2026 at 9:20 AM ET and Barclays Global Healthcare on March 10, 2026 at 1:30 PM ET in Miami, and RBC Virtual Ophthalmology on March 24, 2026 at 8:45 AM ET. Live webcasts and ~30-day archived replays will be available on the company investor website.

ROCKVILLE, Md., March 2, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following investor conferences:

Leerink Partners Global Healthcare Conference
Fireside Chat: Monday, March 9 at 9:20am ET
Location: Miami, FL

Barclays 28th Annual Global Healthcare Conference
Fireside Chat: Tuesday, March 10 at 1:30pm ET
Location: Miami, FL

RBC Inaugural Virtual Ophthalmology Conference 
Fireside Chat: Tuesday, March 24 at 8:45am ET
Location: Virtual

Live webcasts of select events can be accessed in the Investors section of REGENXBIO's website at www.regenxbio.com. Archived replays of the webcasts will be available for approximately 30 days following the events.

ABOUT REGENXBIO Inc.
REGENXBIO is a biotechnology company on a mission to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the field of AAV gene therapy. REGENXBIO is advancing a late-stage pipeline of one-time treatments for rare and retinal diseases, including RGX-202 for the treatment of Duchenne; clemidsogene lanparvovec (RGX-121) for the treatment of MPS II and RGX-111 for the treatment of MPS I, both in partnership with Nippon Shinyaku; and surabgene lomparvovec (ABBV-RGX-314) for the treatment of wet AMD and diabetic retinopathy, in collaboration with AbbVie. Thousands of patients have been treated with REGENXBIO's AAV platform, including those receiving Novartis' ZOLGENSMA®. REGENXBIO's investigational gene therapies have the potential to change the way healthcare is delivered for millions of people. For more information, please visit WWW.REGENXBIO.COM.

Contacts:
Dana Cormack
Corporate Communications
dcormack@regenxbio.com 

Investors:
George E. MacDougall
Investor Relations
IR@regenxbio.com  

View original content to download multimedia:https://www.prnewswire.com/news-releases/regenxbio-to-participate-in-upcoming-investor-conferences-302700392.html

SOURCE REGENXBIO Inc.

FAQ

When will REGENXBIO (RGNX) present at the Leerink Partners Global Healthcare Conference?

REGENXBIO will present a fireside chat on March 9, 2026 at 9:20 AM ET. According to the company, the session takes place in Miami and will be accessible via live webcast in the Investors section of its website.

What time is the REGENXBIO (RGNX) fireside chat at the Barclays Global Healthcare Conference?

The fireside chat is scheduled for March 10, 2026 at 1:30 PM ET. According to the company, the event is in Miami and select events will be webcast live with archived replays available for about 30 days.

How can investors watch REGENXBIO (RGNX) presentations from the March conferences?

Investors can access live webcasts and archived replays on the company's investor website. According to the company, archived replays will be available for approximately 30 days after each event.

When is REGENXBIO (RGNX) participating in the RBC Virtual Ophthalmology Conference?

REGENXBIO will hold a fireside chat on March 24, 2026 at 8:45 AM ET. According to the company, this session is virtual and will be available through the Investors section of its website.

Where will REGENXBIO (RGNX) host archived replays of its March 2026 conference webcasts?

Archived replays will be posted in the Investors section of the company's website for about 30 days. According to the company, select events will be webcast live and then archived for limited replay access.